Horizon Discovery Group (LON:HZD) had its price target trimmed by N+1 Singer from GBX 250 ($3.45) to GBX 230 ($3.18) in a report published on Monday, February 19th. The firm currently has a buy rating on the stock.
Separately, Numis Securities reiterated a buy rating and set a GBX 300 ($4.14) target price on shares of Horizon Discovery Group in a research note on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of Buy and an average price target of GBX 236 ($3.26).
Horizon Discovery Group (LON HZD) traded down GBX 4 ($0.06) during trading on Monday, hitting GBX 175 ($2.42). The company had a trading volume of 57,328 shares, compared to its average volume of 258,719. The stock has a market cap of $275.07 and a P/E ratio of -1,250.00. Horizon Discovery Group has a 52 week low of GBX 160 ($2.21) and a 52 week high of GBX 294 ($4.06).
In related news, insider Susan Galbraith bought 70,000 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The shares were bought at an average cost of GBX 179 ($2.47) per share, with a total value of £125,300 ($173,114.12). Also, insider Jonathan Milner bought 90,492 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The stock was bought at an average cost of GBX 165 ($2.28) per share, for a total transaction of £149,311.80 ($206,288.75).
TRADEMARK VIOLATION WARNING: “Horizon Discovery Group (HZD) Price Target Cut to GBX 230” was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://ledgergazette.com/2018/03/14/horizon-discovery-group-hzd-given-new-gbx-230-price-target-at-n1-singer.html.
About Horizon Discovery Group
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer.
Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.